Preclinical publications from the Zagreb group through the 2000s describe BPC-157 as being in clinical trials for inflammatory bowel disease and refer to it by the Pliva code. Trial registry entries for a pentadecapeptide in ulcerative colitis and in wound healing exist from the same period. Beyond that the record is silent: no efficacy paper, no safety paper, no conference abstract with outcome data.
Pliva was acquired by Barr in 2006 and then by Teva in 2008; the peptide programme did not survive the transitions.
Unpublished trials are common and the reasons are usually commercial, but a reader cannot tell a trial that failed from one that was abandoned for other reasons. The honest statement is that the human data generated two decades ago are unavailable, and that the published human evidence base for BPC-157 therefore remains essentially empty. Every claim about effects in people rests on extrapolation from rodents.
This is the central fact in reading the BPC-157 literature.
Because pages describing the compound as never tested in humans would be wrong, and pages implying human evidence exists would be worse. It was tested; the results were not published. The pack is a research material.
The BPC-157 + TB500 blend is supplied by REVIVE LAB UAE for laboratory research use only, with identity by mass spectrometry and purity by HPLC for each component of the batch. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.
| Format | Strength | Price | Availability |
|---|---|---|---|
| BPC-157 + TB500 Pack | 5 mg + 5 mg | AED 510 | In stock |
Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.
Preclinical publications from the Zagreb group through the 2000s describe BPC-157 as being in clinical trials for inflammatory bowel disease and refer to it by the Pliva code. Trial registry entries for a pentadecapeptide in ulcerative colitis and in wound healing exist from the same period. Beyond that the record is silent: no efficacy paper, no safety paper, no conference abstract with outcome data.
No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.
Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.
Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.